Stock Price
19.41
Daily Change
0.56 2.97%
Monthly
11.30%
Yearly
29.40%
Q3 Forecast
17.95

EPS Reference Time Actual Consensus Previous
2026-11-10 FY2026Q3 0.26 0.21
2026-08-04 FY2026Q2 0.25 0.23
2026-05-05 FY2026Q1 0.17 0.18 0.14
2026-03-03 FY2025Q4 0.18 0.2 0.20
2025-11-04 FY2025Q3 0.21 0.18 0.17



Peers Price Chg Day Year Date
Alliar Medicos A Frente 3.15 0.01 0.32% -38.11% Aug/04
Marisa Lojas 0.57 -0.01 -1.72% -54.03% Aug/04
Arezzo Industria e Comercio 16.04 -0.19 -1.17% -54.96% Aug/04
Americanas 4.71 0.06 1.29% -8.90% Aug/04
C&A Modas 9.72 -0.06 -0.61% -44.17% Aug/04
Clicks 21,865.00 -35.00 -0.16% -41.99% Aug/04
Grup SBF 9.65 0.20 2.12% -11.79% Aug/03
Cogna Educacao 2.34 0.01 0.43% -15.52% Aug/04
Fleury 17.47 0.20 1.16% 22.68% Aug/04
Fomento Economico Mexicano 126.70 0.95 0.76% 43.49% Aug/04

Indexes Price Day Year Date
IBOVESPA 177895 -105.00 -0.06% 33.60% Aug/04

Raia Drogasil traded at 19.41 this Tuesday August 4th, increasing 0.56 or 2.97 percent since the previous trading session. Looking back, over the last four weeks, Raia Drogasil gained 11.30 percent. Over the last 12 months, its price rose by 29.40 percent. Looking ahead, we forecast Raia Drogasil to be priced at 17.95 by the end of this quarter and at 16.46 in one year, according to Trading Economics global macro models projections and analysts expectations.

Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.